By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Benitec BioPharma 

2375 Garcia Avenue

Mountain View  California  94043  U.S.A.
Phone: 650-564-9850 Fax: 650-564-9851



Company News
Benitec (BLT.AX) Acquires Full Rights To Hepatitis B Program 7/9/2015 9:31:24 AM
Benitec (BLT.AX) Files $70 Million IPO As Gene Therapy Booms 6/23/2015 7:42:28 AM
Benitec, Inc. (BLT.AX) Enters Into Strategic Collaboration With ReNeuron To Develop Cellular Therapies 6/22/2015 6:57:23 AM
Benitec, Inc. (BLT.AX) Provides Update On TT-034 Trial 4/7/2015 6:40:46 AM
Benitec, Inc. (BLT.AX) Advances Hepatitis C Clinical Trial 1/7/2015 7:51:10 AM
Benitec, Inc. (BLT.AX) Release: Hepatitis C Trial To Proceed 1/14/2014 9:04:01 AM
Regen BioPharma Licenses Cancer Gene Silencing Technology From Benitec, Inc. (BLT.AX) 8/8/2013 9:47:40 AM
Benitec, Inc. (BLT.AX) Selects University of California, San Diego (UCSD) as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections 4/16/2013 9:34:46 AM
Appointment of Mr Kevin Buchi to Benitec, Inc. (BLT.AX) Board 4/11/2013 11:58:48 AM
Benitec, Inc. (BLT.AX) Selects the Duke Clinical Research Unit as a Site for Hepatitis C Phase I/II Clinical Trial 3/22/2013 9:27:29 AM